| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q1 2020 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IQVIA HLDGS INC | 15 | Q2 2024 | 9.6% |
| UNITED THERAPEUTICS CORP DEL | 15 | Q2 2024 | 9.4% |
| NATERA INC | 15 | Q2 2024 | 10.8% |
| ALNYLAM PHARMACEUTICALS INC | 15 | Q2 2024 | 8.5% |
| ARGENX SE | 15 | Q2 2024 | 7.0% |
| DEXCOM INC | 15 | Q2 2024 | 7.8% |
| AGIOS PHARMACEUTICALS INC | 15 | Q2 2024 | 7.2% |
| GUARDANT HEALTH INC | 15 | Q2 2024 | 3.8% |
| 4D MOLECULAR THERAPEUTICS IN | 15 | Q2 2024 | 2.7% |
| INSPIRE MED SYS INC | 14 | Q2 2024 | 5.9% |
View Eagle Health Investments LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-21 |
| 13F-HR | 2024-08-13 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-10-27 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
View Eagle Health Investments LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.